文献速递心血管胸部CT

心室心肌脂肪:长期生存的意外生物标志物?

Ventricular Myocardial Fat: An Unexpected Biomarker for Long-term Survival?
PubMed 文献 · Eur Radiol · 2018-06-14

回顾性队列研究纳入无心肌梗死患者690例和慢性心肌梗死患者265例,分析非增强胸部CT显示的心肌脂肪与全因死亡率的关系。心肌脂肪与无心肌梗死组死亡风险降低25%(p=0.04)和心肌梗死组降低31%(p=0.018)相关,并改善风险再分类,提示心肌脂肪可能是获益性生物标志物。

要点

  • 非增强胸部CT常见心肌脂肪,无心肌梗死组左心室脂肪25.7%、右心室脂肪49.9%。
  • 心肌脂肪与无心肌梗死组死亡风险降低25%(p=0.04)和心肌梗死组降低31%(p=0.018)相关。
  • 心肌脂肪加入传统风险模型可正确再分类无心肌梗死组22%、心肌梗死组47%。

核心结论

  • 无论有无心肌梗死病史,心肌脂肪患者生存更好,提示心肌脂肪是有益的生物标志物,可能改善风险分层。

研究设计与样本

  • 回顾性队列研究,来自多样化城市学术中心,慢性心肌梗死患者265例与年龄匹配无心肌梗死患者690例,均于2005年1月1日至2008年12月31日接受非增强胸部CT。

关键影像表现/征象

  • CT图像评估左心室和右心室脂肪,无心肌梗死组左心室脂肪25.7%、右心室脂肪49.9%,心肌梗死组左心室脂肪32.8%、右心室脂肪42.3%。
  • 左心室与右心室脂肪高度相关(OR 5.3,p < 0.001)。
  • 心室脂肪与心血管危险因素不相关。

诊断标准与关键数值

  • 无心肌梗死组死亡率40.1%,心肌梗死组死亡率71.7%(中位随访6.8年,平均年龄73.7 ± 10.6岁)。
  • 心肌脂肪与无心肌梗死组调整后死亡风险降低25%(p = 0.04)和心肌梗死组降低31%(p = 0.018)相关。
  • 心肌脂肪加入Charlson评分或钙化评分后,无心肌梗死组正确再分类22%(p = 0.004),心肌梗死组对比Charlson评分正确再分类47%(p = 0.0006)。

临床应用与阅片要点

  • 作者认为心肌脂肪可能提供有临床意义的预后价值,用于患者风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To examine the association between myocardial fat, a poorly understood finding frequently observed on non-contrast CT, and all-cause mortality in patients with and without a history of prior MI.

MATERIALS AND METHODS: A retrospective cohort from a diverse urban academic center was derived from chronic myocardial infarction (MI) patients (n = 265) and three age-matched patients without MI (n = 690) who underwent non-contrast chest CT between 1 January 2005-31 December 2008. CT images were reviewed for left and right ventricular fat. Electronic records identified clinical variables. Kaplan-Meier and Cox proportional hazard analyses assessed the association between myocardial fat and all-cause mortality. The net reclassification improvement assessed the utility of adding myocardial fat to traditional risk prediction models.

RESULTS: Mortality was 40.1% for the no MI and 71.7% for the MI groups (median follow-up, 6.8 years; mean age, 73.7 ± 10.6 years). In the no MI group, 25.7% had LV and 49.9% RV fat. In the MI group, 32.8% had LV and 42.3% RV fat. LV and RV fat was highly associated (OR 5.3, p < 0.001). Ventricular fat was not associated with cardiovascular risk factors. Myocardial fat was associated with a reduction in the adjusted hazard of death for both the no MI (25%, p = 0.04) and the MI group (31%, p = 0.018). Myocardial fat resulted in the correct reclassification of 22% for the no MI group versus the Charlson score or calcium score (p = 0.004) and 47% for the MI group versus the Charlson score (p = 0.0006).

CONCLUSIONS: Patients with myocardial fat have better survival, regardless of MI status, suggesting that myocardial fat is a beneficial biomarker and may improve risk stratification.

KEY POINTS: • Myocardial fat is commonly found on chest CT, yet is poorly understood • Myocardial fat is associated with better survival in patients with and without prior MI and is not associated with traditional cardiovascular risk factors • This finding may provide clinically meaningful prognostic value in the risk stratification of patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Bader AS, Levsky JM, Zalta BA, et al. Ventricular Myocardial Fat: An Unexpected Biomarker for Long-term Survival? Eur Radiol. 2018. PMID: 29948081. doi:10.1007/s00330-018-5546-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。